Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
-5.43M
-
Total reported value, excl. options
-
$256M
-
Value change
-
-$22.5M
-
Put/Call ratio
-
0.72
-
Number of buys
-
72
-
Number of sells
-
-54
-
Price
-
$2.38
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2023
172 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2023.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 170M outstanding shares and own 63% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (19.2M shares), STATE STREET CORP (9.54M shares), FEDERATED HERMES, INC. (8.98M shares), BlackRock Inc. (7.92M shares), VANGUARD GROUP INC (5.48M shares), JANUS HENDERSON GROUP PLC (2.81M shares), Point72 Asset Management, L.P. (2.75M shares), Avoro Capital Advisors LLC (2.5M shares), and Eversept Partners, LP (2.35M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.